Now showing items 1-10 of 23
Burkitt Lymphoma in Uganda. A study of some biological and epidemiological aspects of endemic Burkitt lymphoma
(The University of Bergen, 2011-08-25)
Molecular markers in breast carcinoma. A study with focus on molecular phenotypes, angiogenesis and stem cells in an African population
(The University of Bergen, 2010-09-08)
Gene signatures and prognostic factors in endometrial cancer. A study with special focus on vascular invasion
(The University of Bergen, 2011-04-15)
Time-dependent clock gene expression in mouse and human stem and progenitor cells
(The University of Bergen, 2007-03-30)
Time is a fundamental part of all biological processes. During the whole process of evolution, living cells and organisms had to adapt to cyclic variations in the environment. In particular, the light and temperature ...
Gastric adenocarcinoma: aspects of development and progression in high- and low-risk countries
(The University of Bergen, 2010-03-25)
Experimental studies on the immune response to Ehrlich's ascites carcinoma
(The University of Bergen, 1964-05-13)
pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda
(BioMed Central, 2009-08-19)
Background: The members of the retinoblastoma protein family, pRb, p107 and pRb2 (p130), are central players in controlling the cell cycle. Whereas disturbed function of pRb is commonly seen in human cancers, it is still ...
Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort : a case control study
(BioMed Central, 2006-03-16)
Background: Genetic polymorphisms in DNA repair genes may influence individual variation in DNA repair capacity, which may be associated with risk of developing cancer. For colorectal cancer the importance of mutations ...
Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
(Public Library of Science, 2012-06-15)
Background: VEGF driven angiogenesis plays a key role in cancer progression. We determined the clinical efficacy of bevacizumab monotherapy in patients with metastatic melanoma. Methods and Findings: Thirty-five patients ...